Chengdu, China

Jiangfeng Zhou

This inventor holds 1 USPTO granted patent. Top assignees: Ellipses Pharma Limited, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiangfeng Zhou. Retrieved from https://idiyas.com/inventor/jiangfeng-zhou-mza7r95h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiangfeng Zhou: Innovator in Pyrimidine Compounds

Introduction

Jiangfeng Zhou is a notable inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on pyrimidine compounds. His expertise and dedication to research have led to valuable advancements in this area.

Latest Patents

Jiangfeng Zhou holds 1 patent for his invention titled "Salt and crystal form of pyrimidine compound, and preparation methods therefor." This patent provides a salt and a crystal form of a pyrimidine compound, along with the methods for their preparation. The invention specifically includes a crystal form of the salt, showcasing Zhou's innovative approach to chemical compounds.

Career Highlights

Throughout his career, Jiangfeng Zhou has worked with prominent companies in the biopharmaceutical sector. Notably, he has been associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. and Ellipses Pharma Limited. His work in these organizations has contributed to the development of new therapeutic solutions.

Collaborations

Jiangfeng Zhou has collaborated with esteemed colleagues, including Zheng Gong and Hongming Li. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Jiangfeng Zhou's contributions to the field of pyrimidine compounds exemplify his commitment to innovation and research. His patent and career achievements reflect his significant impact on the biopharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…